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Abstract
Otoconia are bio-crystals anchored to the macular sensory epithelium of the utricle and saccule in the inner ear for motion
sensing and bodily balance. Otoconia dislocation, degeneration and ectopic calcification can have detrimental effects on
balance and vertigo/dizziness, yet the mechanism underlying otoconia formation is not fully understood. In this study, we
show that selected matrix components are recruited to form the crystal matrix and sequester Ca
2+ for spatial specific
formation of otoconia. Specifically, otoconin-90 (Oc90) binds otolin through both domains (TH and C1q) of otolin, but full-
length otolin shows the strongest interaction. These proteins have much higher expression levels in the utricle and saccule
than other inner ear epithelial tissues in mice. In vivo, the presence of Oc90 in wildtype (wt) mice leads to an enrichment of
Ca
2+ in the luminal matrices of the utricle and saccule, whereas absence of Oc90 in the null mice leads to drastically reduced
matrix-Ca
2+. In vitro, either Oc90 or otolin can increase the propensity of extracellular matrix to calcify in cell culture, and co-
expression has a synergistic effect on calcification. Molecular modeling and sequence analysis predict structural features
that may underlie the interaction and Ca
2+-sequestering ability of these proteins. Together, the data provide a mechanism
for the otoconial matrix assembly and the role of this matrix in accumulating micro-environmental Ca
2+ for efficient CaCO3
crystallization, thus uncover a critical process governing spatial specific otoconia formation.
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Introduction
Otoconia, like bone, are a result of ordered deposition of
inorganic calcium carbonate (calcium phosphate in bone)
crystallites onto a pre-formed framework of organic matrix of
glycoproteins. The organic matrix of otoconia is composed of a
predominant glycoprotein plus low-abundant glycoproteins
(collectively called otoconins) and proteoglycans [1–10]. While
bone consists of over 200 proteins, otoconia in mice only have
about 8 components identified to date. The predominant
mammalian otoconial protein is otoconin-90 (Oc90) [7;8], and
the minor murine otoconins are otolin-1 (aka otolin) [10],
osteopontin [11–13], fetuin-A (aka countertrypin) [6;10], Sparc-
like 1 (secreted protein acidic and rich in cysteine, aka Sc1 or
hevin) [6;9], and possibly Sparc, DMP1 (dentin matrix protein)
and a-tectorin [9]. The proteoglycan in murine otoconia is
keratin sulfate proteoglycan (KSPG)[9].
Notably, Oc90 is not related to the predominant bone matrix
protein (collagen I in cortical bone and collagen II in cartilage) or
any other known matrix protein, but rather, it has two domains
resembling secretory phospholipase A2 (sPLA2) [7;8] with 31 and
35% amino acid identity (45% and 48%, respectively, with
conservative variations counted). The predicted tertiary structure
of either domain of Oc90 is almost super-imposable to that of
sPLA2 [9]. However, Oc90 does not have the catalytic activity of
sPLA2 due to substitutions of a few of the critical residues [5;8].
Experimental structure-function analysis has not been done to
demonstrate the functional significance of conservation of the
sPLA2 structure, but the critical features have been analyzed and
modeled [9] and is re-capitulated in the Discussion section of this
report.
Interestingly, the low abundance otoconins either play critical
roles in bone calcification, or belong to the family of essential bone
proteins. For example, otolin contains an N-terminal collagen-like
domain (also called triple helix or TH domain) and a C-terminal
globular (gC1q) domain (also called non-collagenous or NC1
domain) [14], and belongs to the collagen X family and the C1q
super-family. Collagen X is a cartilage-specific collagen important
for the onset of cartilage mineral deposition and the normal
distribution of cartilage extracellular matrix components, espe-
cially proteoglycans, within the growth plate of long bones, ribs,
and vertebrae [15–20]. The TH domain in collagen X contains
Gly-X-Y repeats that are mandatory for the formation of a
collagen triple helix; even a single Gly substitution can destabilize
the triple helix through a local disruption in hydrogen bonding
[21]. C1q members are the target recognition proteins of the
classical complement pathway. C1q proteins bind through its
collagen-like domain to surface receptors of fibroblasts and to
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proteoglycans and laminin [18;22;23]. gC1q is highly conserved,
distinguishes the C1q sub-families and is well known for its
flexibility and versatility in ligand recognition [24;25].
Although only partial details of otoconia formation have been
revealed, this much is clear: the ultrastructure and function of the
otoconial matrix in regulating crystal growth are similar to that in
bone. That is, the matrix proteins in both systems form a fibrous
network [10;26;27] to regulate the growth of the mineral crystals
but neither is involved in the initial mineral accretion [10;28]. In
bone, collagens interact with other important matrix proteins such
as Sparc, osteopontin, bone sialoprotein, fibronectin, vitronectin
[23;29–31]. In otoconia (or fish otolith), evidence suggests that the
critical otoconins may also interact with each other to form the
organic framework for efficient crystallization [Lundberg et al.,
Association for Research in Otolaryngology 2009 Abstract #935]
[10;32;33]. In the absence of Oc90, the otoconia organic matrix,
particularly otolin, is absent (or below detection level) and the
efficiency of crystal formation is reduced by 50% [10]. Therefore,
in the present study, we examined the interactions of Oc90 with
the domains of otolin to gain insight on how the otoconial matrix is
assembled. We also tested whether Oc90 binds KSPG as does
sPLA2 to proteoglycans (particularly heparin sulfate proteoglycan,
as HSPG) [34;35]. Given the known interaction between C1q
proteins and proteoglycans, we tested whether the C1q-containing
otolin interacts with KSPG as well.
While the overall design of matrix formation and subsequent
crystallite deposition is similar between otoconia and bone, details
of the calcification processes differ significantly between the two
systems. For example, a few minor otoconins (i.e. osteopontin and
fetuin-A) that are dispensable for otoconia formation play critical
roles in bone matrix calcification [10]. In bone, osteopontin is a
major non-collagenous protein and influences the organic matrix
over mineral content and limits bone crystal sizes [21;28]. Its role
in bone is similar to that of Oc90 in otoconia [10].
More importantly, unlike the bone milieu, the endolymph
surrounding otoconia has an extremely low concentration of Ca
2+,
making mechanisms of otoconia formation perplexing. In order
for CaCO3 to crystallize, the otoconia organic components must
be able to sequester Ca
2+ to efficiently raise its micro-environ-
mental concentration, which was tested in the present study. In
addition, the expression of some critical protein(s) must be
restricted to or higher in the utricle and saccule than other inner
ear tissues to account for the spatial specificity of otoconia
development. Here we used both in vivo and in vitro approaches to
examine how some critical otoconins participate in otoconia
formation and whether they have higher expression levels in the
otolithic organ.
Materials and Methods
Mice
Oc90 targeted mice were previously generated [10] and
backcrossed to C57Bl/6J (B6) mice. Unless otherwise indicated,
the reported results were all obtained from homozygous mutants.
All animal procedures were approved by the Institutional Animal
Care and Use Committee at the Boys Town National Research
Hospital in accordance with federal and international guidelines
(approval numbers 07-01 and 10-02).
Construction of expression vectors
Transcripts for full-length and domains of proteins were
amplified by RT-PCR of postnatal mouse inner ear tissues, and
unidirectionally cloned into pAAV-IRES-hrGFP (pOc90-FLAG)
and pcDNA3.1 (pOtolin, pOtolin-TH, pOtolin-C1q). GFP is co-
transcribed but not fused with Oc90. For stable transfection, the
full-length Oc90 transcript (stop codon omitted) was also
unidirectionally cloned into pTracer-EF/V5-His(C) (pOc90-His)
using the same restriction sites as below. pOtolin-TH contained
residues 1–342, and pOtolin-C1q contained residues 1–60 fused
with residues 343–482. An existing working antibody recognizes
the N-terminal 17 amino acids of mature otolin (residues 24–40).
The following primers were used to amplify the respective
transcripts: Oc90 forward, 59-ggaattccaccATGATTATGCTGCT-
CATGGTCGGT-39; Oc90 reverse, 59-g ctcgagTTTCCCACCGA-
GGGGTCTGGCCC-39; Otolin forward, 59-gggatccaccATGTG-
GATA TTTTCTTCGCTTTGTGCTG-39; Otolin reverse, 59-
ggaattcTGGTGACTTACTAAAAGTTTCCTCTGGGTACA-39;
Otolin-TH forward, 59- cttggatccATGTGGATATTTTCTT-
CGCTTTG-39; Otolin-TH reverse, 59-t t a gaattcttaGGCCTCG-
CCTTTGGAACCCTT-39; Otolin signal peptide forward, 59-
cttggatccATGTGGATATTTTCTTCGCTTTG-39; Otolin signal
peptide reverse, 59-atcgaattcCGTATGGACGGTTTCTTCT-39;
Otolin-C1q forward, 59-agagaattcACACAAGTCCCACAGTC-
GGC-39; Otolin-C1q reverse, 59-cgtgatatcTTATGGTGACTTAC-
TAAAAG-39. Nucleotides in lower cases were non-endogenous
sequences to create restriction sites (italicized) for cloning, and
restriction enzymes used were EcoR I and Xho I for Oc90; BamH I
and EcoR I for Otolin; BamH I and EcoR I for Otolin-TH; BamH
I, EcoR I and EcoR V for Otolin-C1q. Constructs were confirmed
by DNA sequencing and Western blotting.
Anti-FLAG co-immunoprecipitation (co-IP)
HEK293 cells (ATCC, Manassas, VA, USA) were cultured at
37uC in DMEM containing 4.5 g/L glucose, 100 U/ml penicillin,
4 mM L-glutamine and 10% fetal bovine serum. The cells were
transiently co-transfected with pAAV-Oc90-FLAG-GFP + pOto-
lin (or pOtolin-His or Otolin domains) using FuGENEH HD
transfection reagent (Roche, Indianapolis, IN) and maintained for
48 hrs before harvest for immunoprecipitation.
Co-IP was performed based on a protocol for anti-FLAG M2
affinity gel by Sigma (St. Louis, MO). Briefly, cells were lysed on
ice with gentle hypotonic buffer (10 mM Tris-HCl pH 7.5,
10 mM NaCl, 2 mM EDTA, 0.5% Triton-X-100 and 0.5%
protease inhibitor cocktail) with gentle rocking for 20 min. After
addition of 150 mM NaCl (final concentration), samples were
centrifuged at 13,000 rpm (16,000 g) for 10 min at 4uC, and
supernatants were collected. Aliquots (400 ml) of supernatants were
incubated under constant agitation with 30 ml anti-FLAG-M2
bead slurry (Sigma) for 6 h at 4uC. Beads were washed 3 times
with TBS, and proteins were stripped using 60 ml elution buffer
(0.1 M glycine HCl, pH 3.5) at room temperature and neutralized
with 6 ml buffer (0.5 M Tris-HCl pH 7.4, 1.5 M NaCl). After
centrifugation at 5,000 g for 30 sec, proteins were analyzed by
Western blotting as described below. The primary antibodies were
used at 1:200 for otolin and 1:1000 for Oc90. The secondary
antibody, a horseradish peroxidase (HRP)-conjugated goat anti-
rabbit IgG, was used at 1:10,000 dilution (Sigma).
The interaction of Oc90 and otolin with KSPG was examined
as described in the supplemental Method S1.
Western blotting
Proteins from utricular and saccular epithelia, otoconia and
cultured cells were extracted at 4uC overnight in 10 ml of lysis
buffer containing 40 mM Tris, 4% CHAPS, 8 M urea, 10 mg/
ml DTT and 0.15 M EDTA. After removal of EDTA and salts
using a Centricon column (Millipore, Billerica, MA, USA),
protein concentrations were determined using a Micro-BCA
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USA) following the manufacturer’s protocol. BSA standards were
included to calculate sample protein concentrations.
An aliquot of each sample containing an equal amount of total
protein was mixed with 2X sample loading buffer (0.13 M Tris-
HCl, 20% glycerol, 46 mg/ml SDS, 0.2 mg/ml bromophenol
blue, 20 mg/ml DTT), boiled for 5 minutes, loaded onto a 4–15%
gradient Tris-SDS gel (Bio-Rad, Hercules, CA, USA), electropho-
resed at 100 V in running buffer (25 mM Tris pH 8.3, 192 mM
glycine, 0.1% SDS) for 1–2 hours, and transferred to a PVDF
membrane (Millipore) at 100V for 1 hour. The blot was washed
once with TBST buffer (50 mM Tris, 150 mM NaCl, 0.1%
Tween-20) and treated with 1% blocking buffer (Roche Applied
Science, Indianapolis, IN, USA) overnight at room temperature.
The membrane was incubated with primary antibodies at
appropriate dilutions for 3 hours followed by 3 washes in TBST
buffer, and incubated with a specific peroxidase-conjugated
secondary antibody (Sigma) at 1:10,000 dilution for another hour.
After 3 washes, an ECL detection solution (Pierce, Rockford, IL)
was added for 1 minute, and the blot was exposed to a Kodak X-
ray film and imaged using the Canoscan 8400F imaging station.
Fluorescent immunostaining
Frozen tissue sections (9 mm) were treated with blocking solution
containing 5% goat serum and 0.2% Triton-X-100 at room
temperature for 30 minutes. Primary antibodies were added at a
dilution of 1:100 to 1:600, and incubated at 4uC overnight. After 3
washes in 1xPBS, Alexa-488 or 568 (Molecular Probes, Carlsbad,
CA, USA) conjugated secondary antibodies were added at a
dilution of 1:600, together with DAPI (1:10000), and incubated at
room temperature for 2 hours in the dark. Either null tissues or
non-immune sera (instead of primary antibodies) were used as
negative controls in the preliminary experiment. Slides were
mounted in Fluoromount-G and signals were viewed using a Zeiss
LSM 510 confocal microscope.
Real-time quantitative RT-PCR (qRT-PCR)
Primers and probes for qRT-PCR were purchased from ABI
(Applied Biosystems, Foster City, CA, USA), and qRT-PCR was
done according to the manufacturer’s protocol with minor
modifications based on cDNA samples and primers/probe
conditions. The ABI catalog number for Oc90 primers/probe
was Mm01200961_m1 and otolin Mm01222538_m1.
Total RNA was prepared using Trizol (Invitrogen), and an
equal amount of RNA from each tissue (50 to 100 ng) was reverse
transcribed using the SuperScript III first-strand synthesis system
(Invitrogen). 40 cycles of amplification was achieved in a 96-well
plate consisting of TaqMan Gene Expression Assay, TaqMan
Universal PCR Master Mix and cDNA. The standard mode of an
ABI Prism 7900HT Sequence Detection System was used, and b-
actin was amplified in parallel as an endogenous control to
standardize the amount of sample added to a reaction and for the
quantification of the relative gene expression within and between
samples. All reactions were performed in triplicates.
Cell culture and stable transfection
NIH/3T3 cells (ATCC) were cultured in DMEM containing
4.5 g/L glucose, 100 U/ml penicillin, 4 mM L-glutamine and
10% fetal bovine serum. Conventional culture condition was used
at 37uC in a humidified incubator supplemented with 5% CO2.
The cells were transfected with pOc90-His and pOtolin, alone or
together, and with the empty vector pcDNA3.1 or pTracer
TM-
EF/V5-His using FuGENEH HD (Roche Applied Science,
Indianapolis, IN). Stably transfected clones were selected over a
two-week period using 400 mg/ml Zeocin for pOc90-His, or
800 mg/ml G418 for pOtolin. Selected clones were then expanded
and analyzed for calcification potential as described below.
Induction of calcification
To induce ECM (extracellular matrix) mineralization, stable
NIH/3T3 clones expressing pOc90-His, pOtolin, pOc90-His +
pOtolin, pTracer
TM-EF/V5-His and pcDNA3.1 were treated with
0.5 mM Ca
2+ (CaCl2) and 2 mM Pi (Na2HPO4) in growth media
to provide a source of inorganic components for mineralization.
Phosphate, instead of carbonate, was used so as not to alter the
optimal pH and CO2 content. After 5 days of induction, cells were
fixed with 4% PFA, and stained with Alizarin Red S (ARS)
(Chemicon, Billerica, MA). The effects of various Ca
2+ and Pi
concentrations were tested in the preliminary experiments to
determine the optimal condition at which the effects of Oc90 and
otolin were best differentiated from empty vectors. In order to
minimize variations caused by the effect of cell density on
calcification, cells were seeded at a density (2610
4 cells in each
well of the 24-well plate) so that each well was grown to confluence
when calcification was examined on the 6
th day. The supplemental
Ca
2+ and Pi reduced the proliferation rate of all cells, whether they
were transfected or not. Calcification nodules and total cells were
photographed and counted for each 20x view field under an
inverted microscope (approximately 1.2 mm
2); averaged ratios of
nodules/total cells were compared among transfectants and the
vector using the Student’s t-test.
Ratiometric calcium measurement
The ECM-Ca
2+ content of Oc90 null and wt tissues was
determined using the ratiometric dye, Fura-2 (Molecular Probes,
Eugene, OR). Fura-2 was used for the particular goal because
micro-electrodes only measure free Ca
2+, and Alizarin Red
staining for calcium deposits (calcium phosphate/carbonate) is
not sensitive enough to stain the early stage of crystal seeds [10],
nor does it detect immobilized Ca
2+.
Both fixed and unfixed tissues were tested for comparison.
Epithelia from the utricle+saccule, canal+ampulla, and cochlea
were dissected in artificial endolymph with or without fixation,
were then soaked at 4uC overnight in 5 ml cell fura-2
pentapotassium salt (Invitrogen) in Ca
2+ free Ringer solution.
The cell- and matrix-free supernatants were then diluted 10 fold
with a Ca
2+ free Ringer solution, and an aliquot of test solution
was placed in a sealed glass pipette and imaged using a cooled
CCD camera (SensiCam, Cooke Corp., La Jolla, CA) on an
upright fixed stage microscope (Nikon E600FN, Garden City,
NY). Axon Imaging Workbench (AIW 2.2, Axon Instruments) was
used to control the camera, filter wheel (Lambda 10-2, Sutter
Instruments, Novato, CA), and image acquisition. [Ca
2+] was
calculated from the ratio of light emitted at 510 nm during
alternate excitation by 340 and 380 nm light [36]. Calibration
constants (standard curve) were determined using a series of highly
buffered Ca
2+ test solutions (Molecular Probes), and Ca
2+
concentrations eluted from the ECM of each tissue from each
animal were determined using the standard curve. Occasional
statistical outliers (. +2SD or ,2 2SD) were excluded from
further analysis.
Due to the high sensitivity of the assay, there were some
variations in the absolute readings between experiments done on
different days, therefore, measurements from the same batch (done
on the same day) consisted of both Oc90 wt and null genotypes of
each age group to obtain wt/null ratios. Wt/null ratios were used
also because the endolymph volume covering the mouse utricular
and saccular macula ECM is unknown and the Ca
2+ is presumably
Matrix Proteins in Otoconia Development
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absolute concentrations of micro-environmental Ca
2+.
Data analysis
Statistical analysis was performed using the Student’s t-test. P
values of less than 0.05 were considered significant.
Molecular modeling
To model the C1q domain of otolin (Swiss-Prot id Q4ZJM7),
we used I-TASSER server [37] to search mouse otolin-C1q
domain sequence (amino acids 343–478) against PDB database
[http://www.rcsb.org/pdb/home/home.do]. Ten templates from
three structures (PDB id 1a05A, 1cnzB and 1cnzA) were used to
build a hybrid homology model. We then used GROMACS [38]
to optimize the structure by molecular dynamics (MD) simulations
via three steps: (1) energy minimization in 1.2 ps; (2) position-
restrained molecular dynamics in 50 ps to soak the water/ion
molecules into the domain structure; and (3) molecular dynamics
simulation in 1000 ps. All simulations were done in the condition
of 150 mM NaCl solution at 37uC. Modeling of the TH domain of
otolin was similarly done.
Results
Oc90 interacts with both domains of otolin but prefers
the full-length protein
To test whether Oc90 interacts with otolin to form the organic
matrix of otoconia and to identify the interacting domains, we
performed co-immunoprecipitation (IP). Transfection of HEK293
cells with expression constructs containing full-length Oc90 (Oc90-
FLAG), full-length and individual domains of otolin (TH and C1q)
yielded high expression efficiency (Figure 1B, 1C). Protein
products were co-precipitated using anti-FLAG agarose beads
and washed under stringent conditions as described in Materials
and Methods. Constituents eluted from the beads were analyzed
by Western blotting after separation by 4–15% SDS-PAGE
(Figure 1A). Antibodies against the N-terminal regions of Oc90
and otolin [10] were used for detection. Oc90 interacts strongly
with full-length otolin (lane 2 in Figure 1A), and both domains of
otolin participate synergistically in this interaction (lanes 3 and 4 in
Figure 1A). The requirement of both otolin domains is consistent
with the finding that the C1q domain of other related proteins is
responsible for partner recognition and the TH domain for
strengthening the interaction [22]. Both the TH and C1q domains
have a high affinity for proteoglycans and Ca
2+ as well [39]. As is
the case with the sPLA2-like domains in Oc90 [8;9], the functional
domains of otolin (TH and C1q) are extremely conserved
throughout evolution [32].
As the main Xenopus saccular otoconin Oc22 [40] only has one
sPLA2-like domain and does not have the N- or C-terminal region
of Oc90, we predicted that a single sPLA2-like domain of Oc90
will be able to bind otolin and, therefore, did not test each Oc90
domain alone. Instead, we further tested whether Oc90 or otolin
interacts with KSPG, another otoconia component of low to
intermediate abundance. Because Western blotting of KSPG tends
to produce a smear due to non-homogeneous degree of
glycosylation, we used protein A agarose beads to bind an
antibody for KSPG, followed by incubation with KSPG and Oc90
(or otolin) extracted from otoconia, vestibular epithelia or
transfected cells. As shown in the supplemental Figure S1, the
co-IP reaction produced a weak band of Oc90 (or otolin) in the
reaction containing anti-KSPG+KSPG+Oc90 (or otolin), but not
in the reaction containing mouse IgG+KSPG+Oc90 (or otolin)
control, therefore, the reaction was likely specific albeit weak.
KSPG is present in Oc90 null otoconia and vestibule in a way
similar to that in wt tissues [9], further suggesting weak
interactions between these two components. The weak interaction
between Oc90 (or otolin) and KSPG is also consistent with the
observation that KSPG is low in the crystals but abundant in the
otoconial membrane (OM) (Figure 2), whereas the expression of
both Oc90 and otolin is higher in the crystals than the OM. Based
on our previous mass spectrometry data [10], Oc90 is much more
abundant in the crystals than otolin, which is evident here by the
fluorescence intensity in the Figure 2. Different tissue sections were
used for Oc90 and otolin immunostaining simply because of their
availability at the time of the experiment; based on previous
observation [10], the utricle and saccule have similar patterns of
presence of the two proteins.
Oc90 and otolin have much higher expression levels in
the utricle and saccule than the semi-circular canals or
cochlea
In order to examine whether Oc90 and otolin have higher
expression levels in the utricle and saccule that may contribute to
the spatial restriction of otoconia formation in these tissues, we
performed qRT-PCR analysis of inner ear epithelial tissues
dissected from E17.5 (embryonic day 17.5), P0 (postnatal day 0)
and P7 wt mice. As shown in Figure 3, the expression levels of
Oc90 and otolin were 10 to 20 times higher in the utricle and
saccule than the cochlea at E17.5 (p,1.4 X10
26 and
p,1.6X10
26, respectively, n=3, indicated by *** in Figure 3).
The Oc90 mRNA level in the utricle and saccule drastically
reduced at around P7 as compared with that at E17.5 and
neonatal (P0) stages (p,7.4X10
26 and p,2.0X10
26, respectively,
n=3, indicated by
### and
$$$ in Figure 3C). The vestibular
samples in Figure 3C and 3D mainly consisted of the
utricle+saccule with a small part of the ampulla. The changes in
Oc90 mRNA levels at these stages coincide with the growth and
Figure 1. Co-immunoprecipitation (co-IP) of Oc90 with otolin
or its domains. HEK293 cells were transfected with full-length Oc90-
FLAG, otolin and domains of otolin. Shown in (B, C) are Oc90-FLAG and
otolin detected by immunostaining. In (A), protein products were co-
immunoprecipitated using anti-FLAG agarose beads. The lanes are co-IP
with: 1) empty vectors, 2) full-length (FL) otolin, 3) otolin-TH domain,
and 4) otolin-C1q domain.
doi:10.1371/journal.pone.0020498.g001
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PLoS ONE | www.plosone.org 4 May 2011 | Volume 6 | Issue 5 | e20498Figure 2. Relative presence of Oc90, otolin and KSPG in neonatal B6 otoconia. (A, C) Abundant presence of Oc90 in otoconia crystals
(labeled as ‘O’). (D, F) Otolin antibody showed staining in both the sensory epithelium (labeled as ‘SE’) and otoconia. (B, C, E, F) KSPG had a low level
in the crystals but showed intense staining in the otoconia membrane (labeled as ‘OM’). O, otoconia; OM, otoconia membrane; SE, sensory
epithelium; HC, hair cells; SC, supporting cells.
doi:10.1371/journal.pone.0020498.g002
Figure 3. Oc90 (A, C) and otolin (B, D) expression levels in murine inner ear. Quantitative real-time RT-PCR (qRT-PCR) showed that both
Oc90 and otolin had significantly higher expression levels in the utricle and saccule than the ampulla, canal or cochlea in wt mice. The mRNA levels
were normalized to that of b-actin (relative mRNA level), and then different tissues were compared to the utricle and saccule whose relative mRNA
level was set to 1 (A, B). In (C, D), the relative mRNA level in the E17.5 cochlea was set to 1. The vestibular samples in C and D mainly consisted of the
utricle+saccule with a small part of the ampulla. ** and *** denote p,0.01 and 0.001, respectively, when the utricle+saccule are compared with other
tissues (n=3 for each type of tissue in each age group). ### and $$$ denote p,0.001 when P7 is compared with E17.5 and P0, respectively.
doi:10.1371/journal.pone.0020498.g003
Matrix Proteins in Otoconia Development
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otolin mRNA levels show smaller changes across ages. This,
together with the relatively late onset of otolin expression in the
utricle and saccule, likely reflects a possible role of otolin in crystal
growth and maintenance. In contrast, the early onset of Oc90
expression [7;8] reflects its role in crystal seeding and growth [10].
The expression of either gene in adult tissues was extremely low
(data not shown).
Oc90 (or Oc90-otolin complex) sequesters Ca
2+ in vivo for
optimal otoconia formation
In order for otoconia to form in the low [Ca
2+] endolymph,
participating proteins must be able to bind and sequester Ca
2+ for
efficient CaCO3 crystallization. Indeed, all of the otoconial
proteins known to date have Ca
2+-binding motifs or structural
features. If so, there may be a higher matrix-Ca
2+ content in the
utricle and saccule in the presence of otoconial proteins such as
Oc90 and otolin as compared to that in their absence.
Furthermore, the matrix-Ca
2+ may be higher in the utricular
and saccular matrix where otoconia are formed and where
otoconial proteins such as Oc90 and otolin have much higher
expression levels, and lower in the ampulla/canals and cochlea
where no otoconia are present under normal physiological
conditions.
The difficulty lies in finding or developing a sensitive assay
suitable for the minute tissue and matrix to be tested. Due to the
high affinity of Fura-2 and the relatively low affinity of matrix
proteins for Ca
2+ [e.g., the affinity of fura-2 for Ca
2+ is ,0.14 mM,
whereas the affinity of Col10a1 for Ca
2+ is around 32 mM] [41],
we were able to use fura-2 to extract the immobilized Ca
2+ from
the luminal surface and measure the Ca
2+ content in the cell- and
matrix-free supernatant. The pentapotassium salt of fura-2 is cell
impermeant; nevertheless, we tested both fixed and unfixed tissues
to detect any possible bias that may have arisen from Ca
2+
outfluxes from intra-cellular sources. Not surprisingly, fixed and
unfixed tissues gave similar measurements, likely because only
Ca
2+ in the extracellular solution was being examined.
By applying the fura-2 calibration kit, we indeed detected the
trend hypothesized above (Figure 4). In the figure, the Oc90 wt/
null ratios were obtained by using the averaged [Ca
2+] values
(based on the in vitro solution volume of 50 ml) from each tissue,
genotype and age group (n=8–16 in each group). Oc90 wt/null
ratios of matrix-Ca
2+ content in E17.5- and 7-week-old mice were
consistently 8–9 in the macular matrix, but there was no
significant difference between the two genotypes in the cochlear
matrix where both genotypes produced low measurements. A
preliminary test of wt and null canals (including the ampulla ends)
showed an outcome similar to that of the cochlea (data not shown).
Maintenance of the macular matrix-Ca
2+ content at the onset of
murine adulthood, a stage considerably beyond the postnatal
otoconia growth period (growth arrests at around P7), suggests a
requirement for maintenance or possible potential for regenera-
tion/neogenesis. Regardless of the gene expression levels after
early postnatal stages, the matrix proteins are still present or even
abundant (i.e. Oc90) [10] likely due to their stability.
From these data, we conclude that Oc90 (or Oc90-otolin
complex) is important to sequester Ca
2+ in the utricular and
saccular ECM for spatial specific otoconia development in wt
mice.
Oc90 and otolin synergistically augment ECM
calcification in cell culture
We then established a cell culture system to test whether the
presence of Oc90 and/or otolin can augment matrix calcification.
NIH/3T3 cells stably transfected with Oc90 and/or otolin showed
intense ECM calcification after 5 days of induction with 0.5 mM
Ca
2+ and 2 mM Pi (Figure 5). The Ca
2+ concentration used here is
much lower than that used in osteoblast calcification studies (a
minimum of 2 mM for the latter); the Pi concentration is slightly
lower too (a minimum of 2.5 mM for the latter) [42]. In the figure,
inorganic calcium deposits were visualized with ARS staining, and
percentages of cells with ECM calcification over total cells were
obtained in each sample. No calcification was seen in untrans-
fected or transfected cells cultured in standard media without
additional supplements of Ca
2+ and Pi (Figure S2). Under
inducing conditions, ratios of cells with ECM calcification were
similar between untransfected cells and cells transfected with
empty vectors. Among cells stably transfected with otolin, an
average of 4.060.4% had calcification nodules, as compared to
2.560.2% for those transfected with the empty vector under
inducing conditions (Figure 5A & 5B) (p,0.001, n=3 experiments
x 3 survey fields in each). The effect of Oc90 on calcification
Figure 4. Oc90 sequesters Ca
2+ in vivo. Oc90 wt/null ratios of matrix-Ca
2+ content in E17.5 and 7 week-old mice as measured with a cell
impermeant fura-2 calibration kit (n=8–16 in each tissue, age and genotype group). *** indicates p,0.001 between measurements of the
utricle+saccule vs. cochlea.
doi:10.1371/journal.pone.0020498.g004
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Co-transfection of Oc90 and otolin had a synergistic effect on
calcification, with 5.660.6% cells showing matrix calcification
(p,0.05 vs. Oc90 transfectants, and p,0.001 vs. otolin transfec-
tants). Due to the large numbers of total confluent cells in each
view field, the percentages of cells with calcification nodules
became small, but the differences between Oc90 (or otolin or
Oc90+otolin) transfectants versus empty vectors were visually
obvious even without a microscope. Therefore, the presence of
Oc90 and/or otolin significantly increases the propensity of the
extracellular matrix to calcify.
Structural analysis and molecular modeling predict
critical features that may underlie the Oc90-otolin
interaction and Ca
2+-sequestering ability
Our recent structural analysis of Oc90 shows that some
functionally critical features can be modeled and predicted from
known crystal structures of their homologs and paralogs [9],
Figure 5. Oc90 and otolin augment ECM calcification. Inorganic calcium deposits were visualized with Alizarin Red S staining, and averaged
percentages of cells with ECM calcification over total cells were compared for different constructs and vectors. Under the same inducing conditions,
untransfected cells and cells transfected with empty vectors (A) had similar ratios of calcification nodules, but both had significantly lower ratios than
those transfected with otolin (B), Oc90 (C), or Oc90+otolin (D) (Figure 5B, 5C or 5D vs. 5A, p,0.001 as denoted by ***, n=3 experiments x 3 fields for
each). Figure 5E shows histograms of the averaged percentages of cells with ECM calcification. Co-transfection of Oc90 and otolin had a synergistic
effect on calcification. # and ### indicate p,0.05 and 0.001, respectively, when pOc90 or pOc90+pOtolin is compared with pOtolin. $ indicates
p,0.05 when pOc90+pOtolin is compared with pOc90.
doi:10.1371/journal.pone.0020498.g005
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otolin complex goes through a significant conformational change
upon contact. Here we utilized the high degree of sequence
similarity between otolin (Swiss-Prot id Q4ZJM7) and type X
collagen (Col10a1) (Swiss-Prot id Q05306) (Figure 6) and modeled
the tertiary structures. Both proteins belong to a subgroup of the
collagen family and the C1q super-family (the two families have
overlapping subgroups). Otolin has 74 characteristic Gly-X-Y
repeats and Col10a1 has 129 Gly-X-Y repeats in the collagen-like
domain, where X is frequently Proline (Pro) and Y hydroxyproline
in collagen. Otolin has fewer Pro residues, with 36 total Pro and 15
in Gly-X-Y repeats. Nevertheless, molecular modeling shows that
the TH domain of otolin resembles the structure of human
COL10A1 [43]: it also has a linear architecture with a flexible and
dynamic structure and will likely form a triple helix.
Both otolin and Col10a1 have a highly conserved C-terminal
globular C1q (gC1q) domain, sharing 68% amino acid sequence
similarity to each other, with 55 identical (*), 20 conservative (:)
and 18 semi-conservative (.) residues among a total of 136aa
(Figure 6). The inter-subunit contacts in the trimer are almost
entirely hydrophobic with key contact residues highlighted in
yellow in Figure 6. Thirteen out of 20 residues in Col10a1 are
conserved in otolin. Based on molecular modeling results, the
tertiary structures of murine otolin and Col10a1 are nearly super-
imposable (Figure 7A). Most importantly, the two critical aspartic
acids (D, highlighted in Figures 6 & 7) that provide the ligands for
a cluster of four Ca
2+ ions in Col10a1 are conserved in otolin
(E422 binds Ca
2+ equally well). With other residues (R421 and
Y425), they form a pocket with high temperature factors for Ca
2+
binding (Figure 7B, E). Additionally, a stretch of nine positively
Figure 6. Alignment of murine otolin and collagen X-a1 (Col10a1). The collagen-like domain, aka triple helix (TH) domain, of otolin and
Col10a1 have a repeating (Gly-X-Y)n (the shaded ‘G’s denote Glycine), where X is frequently Proline and Y hydroxyproline. The TH domain starts at
residue 130 and ends at residue 342 in otolin. The C-terminal globular C1q (gC1q) domain starts at residue 343 in otolin. In collagen, this domain is
also known as the non-collagenous NC1 domain. The two D’s (blue) denote aspartic acids in Col10a1 that provide the ligands for a cluster of four Ca
2+
ions. These residues are conserved in otolin. The inter-subunit contacts are almost entirely hydrophobic with key contact residues highlighted in
yellow. Most of these residues are conserved in otolin. Residues 1–23 in otolin and 1–18 in Col10a1 are the signal peptides, respectively; residues 19–
56 in Col10a1 is the non-collagenous NC2 domain, and 24–36 in otolin is the residual NC2-like domain. * : . indicate identical residues, conservative
and semi-conservative variations, respectively, between otolin and Col10a1.
doi:10.1371/journal.pone.0020498.g006
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several hydrogen-bonding residues (Figure 7C), which constitutes a
large cationic and hydrogen-bonding surface and should represent
a putative functional site/region for Oc90 binding. Possible
electrostatic interactions and hydrogen bonding between otolin
and Oc90 is further supported by the clustering of anionic and
hydrogen-bonding residues on the surface of a modeled Oc90
structure [44]. At the physiological pH, otolin has a net positive
charge of 11.5 with a predicted pI of 9.2, and Oc90 has a negative
charge of 223.0 with a predicted pI of 4.5. The non-polar residues
may also facilitate the interaction of otolin with Oc90. Clustering
of non-polar residues was also found on the surface of murine
Oc90 [45] and bullfrog Oc22 [44], a homolog of Oc90 but with
only one sPLA2-like domain.
Figure 7D shows the root mean square deviation (RMSD) of the
backbone atoms along the trajectory, which is used to assess the
structural stability of the homology models. The RMSD of the
otolin-C1q domain (residues 343–482) shows that during simula-
tion the structures quickly reached equilibrium and then they are
fluctuated around an average structure. Good quality of the
modeled structure is indicated by the low RMSD value (0.21 A ˚)o f
the time-averaged structure and a TM-score (estimated accuracy
of the model) of 0.87. Figure 7E shows the RMS fluctuations used
to map the surface residues of the modeled structure in Figures 7B
and 7C. Low RMS fluctuations are indicative of tighter bound
complexes, whereas high fluctuations suggest surface residues.
Discussion
Otoconia-related balance disorders are prevalent. For example,
benign paroxysmal position vertigo, a disease believed to be
caused by otoconia dislocation with possible degeneration, is the
most common form of dizziness. In order to uncover the molecular
etiology of such disorders, we began by studying the mechanisms
underlying otoconia development. In this study, we have
demonstrated that Oc90 interacts with both domains of otolin to
form the otoconial matrix framework, and this complex sequesters
Ca
2+ in the ECM for efficient calcification. These proteins have
Figure 7. Molecular modeling of the C1q domain of otolin. (A) The tertiary structures of Col10a1-C1q domain (green) and otolin-C1q domain
(magenta) are nearly super-imposable. The modeled structure is consistent with the crystal structure of human COL10A1. Ca
2+-binding residues are
labeled and projected as sticks. (B) The surface of the otolin-C1q domain with temperature factors denoted in different colors. (C) Clustering of
residues and the cationic surface of otolin-C1q domain. Residues are colored according to their electrical charges and hydrophobic nature. The nine
key cationic residues are labeled and projected as sticks. (D) The protein backbone RMSD during 1ns simulation. After 400ps, the structure is stable.
The 400–1000 ps range was used for computing the final structure. (E) The temperature factor (RMS fluctuation) of each residue. The residues with
higher RMS fluctuation usually are exposed on molecule surface and may construct active sites. The Ca
2+-binding residues in (A) are labeled.
doi:10.1371/journal.pone.0020498.g007
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cochlea or canal/ampulla, likely contributing to the spatial specific
formation of bio-crystals. Based on what is known of bone matrix
proteins, the affinity of the otoconial matrix proteins for Ca
2+ is
not expected to be high. However, the affinity of otoconial
proteins does not need to be high for the proposed function to
occur, as the micro-environmental Ca
2+ level may be high due to
the activities of nearby Ca
2+ channels and pumps such as Atp2b2
(also called Pmca2, or plasma membrane Ca
2+-transporting
ATPase 2). ECM-immobilization of Ca
2+ serves two important
purposes: (1) The high ECM-Ca
2+ content provides a reservoir for
otoconia formation, maintenance and neogenesis, and (2) The
ECM is able to reduce the micro-environmental Ca
2+ that is
extruded by ion pumps/channels, as high Ca
2+ is not conducive
for optimal hair cell function.
The interaction of Oc90 and otolin is not surprising, as its
structural paralog sPLA2 can induce collagen deposition in the
vascular wall [46]. Notably, several collagen-binding proteins
(such as Sparc, integrin, osteopontin, bone sialoprotein, fibronec-
tin, vitronectin, see Introduction for references) do not share any
sequence similarity. Likewise, there is no sequence similarity
between Oc90, Sc1 (or Sparc) and the predominant matrix protein
in bony fish, otolith matrix protein (OMP), yet, all these otoconia/
otolith proteins function similarly in calcification. For example,
Sc1 is incorporated in the absence of Oc90 and partially
compensate for the loss of Oc90 function [9]; OMP was found
to recruit otolin [33], despite a lack of sequence similarity between
Oc90 and OMP. This phenomenon points to the possibility that
certain residues, motifs, and tertiary features may be necessary and
sufficient for binding matrix proteins and calcite (or apatite) during
otoconia/otolith formation. Indeed, Oc90, Sc1 (or Sparc) and
OMP all share the following critical features that are faithfully
conserved throughout evolution: (1) All are very acidic due to the
large numbers of Glu and Asp residues. These residues confer a
high affinity for calcium phosphate [47;48] and calcium
carbonate. (2) All bind bivalent cations (e.g. Ca
2+). (3) All bind
otolin and/or other types of collagen [10;32;49–51]. The con-
served functional domains of Oc90, Sc1 and Sparc have a-helices
[9] that may be important for interacting with Ca
2+, calcium
carbonate/phosphate crystals or matrix proteins. (4) All are rich in
Cys residues, which are predicted to form intra- and possibly inter-
molecular disulfide bridges to form a rigid and stable framework
for ordered mineral deposition. (5) All are glycosylated, another
feature that endows the protein with an affinity for Ca
2+. (6) Both
Oc90 and OMP are expressed in all non-sensory epithelia of the
developing otocyst [33;52].
The types of interactions (electrostatic, hydrogen-bonding, and
hydrophobic) we predicted between Oc90 and otolin may also
occur between the two proteins and KSPG. Corneal KSPG has
been shown to have a somewhat rigid conformation and is stable,
likely due to disulfide bonds [53]. Similar to other proteoglycans
(i.e. HSPG) [54], KSPG interacts with collagen through
electrostatic interactions. In addition, KSPG possesses significant
surface hydrophobicity that allows it to bind lipid assemblages
[53].
In the absence of Oc90, Sc1 or even some residual otoconial
components (e.g. KSPG, osteopontin and fetuin-A) in the macular
ECM may sequester Ca
2+ for CaCO3 seeding albeit with reduced
efficiency. Indeed, Sc1 can enhance matrix calcification as well
[9]. Possible functional redundancy among a few otoconins in vivo
is further suggested by the fact that several other otoconins, in
addition to Oc90, can also regulate crystal growth and
morphology in vitro [44;45] but are dispensable for otoconia
formation in vivo (i.e. osteopontin, fetuin-A). Apparently, this
redundancy cannot efficiently compensate for the loss of Oc90 in
vivo [9;10].
Alternatively, the insignificance of the other proteins in otoconia
formation may be due to their low abundance. However, Oc90
has relatively low abundance in the zebrafish otolith (known as
Otoc1) [55], and yet Oc90 knockdown mutants show a range of
phenotypes including missing, aberrant, small to normal otoliths
[55]. These phenotypes are more severe than those of OMP1
morphants [33;55], suggesting that zOc90 (Otoc1) is essential for
the early stages of otolith development (i.e. crystal seeding)
whereas OMP regulates crystal growth. The onset of Oc90
expression is the earliest among all otolith/otoconia proteins in
zebrafish and mice (before E9.5 in mice) [7;8;55], much earlier
than the onset of any activities of ion channels/pumps. Oc90 then
recruits other components at the time of their expression to form
the organic matrix prior to onset of calcification [10]. Thus, the
structure and function of Oc90 is conserved from bony fish to mice
(two model systems whose otoconia/otolith are the most studied)
regardless of the abundance of the protein in each species.
Our data show that otolin shares high structural and functional
similarity to Col10a1. Conservation of the Col10a1 features in
otolin may render the protein extremely stable. Native Col10a1
forms a strong, non-covalent trimer that is not disrupted even
under reducing agents [43]. The trimers then form a higher order
aggregate [43]. The crystal structure of human COL10A1 shows
an absence of disulfide bridges [56–58]. Like Col10a1, otolin only
has 1 Cys residue, but it may be unnecessary to form inter-
molecular disulfide bridges as well.
Although both NC1 and NC2 domains of Col10a1 were
proposed to be important for intermolecular interactions and the
formation of extracellular supramolecular assemblies [59], studies
have addressed mostly the structure and function of the C-terminal
NC1 domain. The NC2 domain in otolin is even shorter (13
residues as compared to 37 in Col10a1, excluding signal peptide)
and less conserved than the rest of the protein, therefore, we
focused on the NC1 domain in our analysis.
In summary, the present study has uncovered an important
mechanism responsible for the specific recruitment of otoconia
matrix components for optimal and spatial specific otoconia
formation. These components, especially the predominant otoco-
nin Oc90, are critical to sequester Ca
2+ for normal otoconia
formation. Structural analysis suggests important features under-
lying such functions. In the process, we have developed a sensitive
assay utilizing ratiometric fura-2 to quantify the matrix-Ca
2+
content as an indicator of its potential to calcify. Future studies will
identify additional mechanisms (e.g. the role of regulatory proteins
such as Otop1, Nox3 and Noxo1) that likely exist to determine
spatial specific biomineralization. It should be noted that, after
much endeavor of the bone field, mechanisms underlying spatial
restriction of mineralization to bone are still controversial and are
far from being fully resolved. It is thus anticipated that a large
amount of continuous effort will be required to achieve similar
goals in the otoconia field as well.
Supporting Information
Figure S1 Co-immunoprecipitation of Oc90 and otolin
with KSPG. (Top) KSPG antibody (labeled as a-KSPG) pulled
down Oc90 from extracts of otoconia (O) and vestibular epithelia
(Ve) but not when mouse IgG was present. (Bottom) KSPG
antibody pulled down otolin from transfected HEK293 cells
(labeled as ‘‘cell’’) and vestibular epithelia, but not when mouse
IgG was present.
(TIF)
Matrix Proteins in Otoconia Development
PLoS ONE | www.plosone.org 10 May 2011 | Volume 6 | Issue 5 | e20498Figure S2 No calcification without Ca
2+ and Pi. No
calcification was seen in any of the cells without supplemental
Ca
2+ and Pi (pOtolin transfectants are shown here). ARS staining
was performed in the same way as for Figure 5.
(TIF)
Method S1 Co-immunoprecipitation (co-IP) of Oc90,
otolin and KSPG for Figure S1.
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